Richard Moscicki, M.D.
Chief Medical Officer
Executive Vice President
Pharmaceutical Research and Manufacturers of America (PhRMA)
Richard (Rich) A. Moscicki (Mo-shis-ke), M.D., joined the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), as Deputy Center Director for Science Operations. A nationally recognized expert in clinical research and development, Dr. Moscicki brings to the position executive direction of Center operations and leadership in overseeing the development, implementation, and direction of CDER’s programs.
Before joining CDER, Dr. Moscicki served as senior vice president (SVP), Head of Clinical Development, and chief medical officer at Genzyme Corporation. He joined Genzyme in 1992. Over the past two decades, Dr. Moscicki has been responsible for worldwide global regulatory and pharmacovigilance matters, as well as all aspects of clinical research and medical affairs for the company.
Dr. Moscicki received his medical degree from Northwestern University Medical School. He is board certified in internal medicine, diagnostic and laboratory immunology, and allergy and immunology. He completed his residency in Internal Medicine, followed by a fellowship at Massachusetts General Hospital (MGH) in immunology and immunopathology. He remained on staff at MGH and on the faculty of Harvard Medical School from 1979 until 2013.